(Q52850198)

English

Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders.

scientific article published in February 2009

In more languages
default values for all languages
No label defined

No description defined

Statements

Canakinumab, a fully-human mAb against IL-1beta for the potential treatment of inflammatory disorders (English)
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit